Ignite Creation Date:
2025-12-24 @ 9:59 PM
Ignite Modification Date:
2026-06-10 @ 7:37 AM
Study NCT ID:
NCT01307332
Status:
COMPLETED
Last Update Posted:
2018-10-16
First Post:
2011-01-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Advanced MRI Measures of Repair in Alemtuzumab Treated Patients
Sponsor:
University of British Columbia
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Relapsing Remitting Multiple Sclerosis | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Multiple Sclerosis | View |
| None | MS | View |
| None | Relapsing Remitting Multiple Sclerosis | View |
| None | RRMS | View |
| None | Alemtuzumab | View |
| None | Demyelination | View |
| None | Remyelination | View |
| None | Tolerogenic | View |
| None | T cells | View |
| None | Demyelinating Autoimmune Diseases, CNS | View |
| None | Autoimmune Diseases of the Nervous System | View |
| None | Nervous System Diseases | View |
| None | Demyelinating Diseases | View |
| None | Autoimmune Diseases | View |
| None | Immune System Diseases | View |